Evidence map›Paper›PMID 39356313›Full record

ArticleActa neurochirurgica2024

Long-term analysis of ABI auditory performance in patients with neurofibromatosis type 2-related schwannomatosis.

Hannah Daoudi, Renato Torres, Isabelle Mosnier, Emmanuelle Ambert-Dahan, Amélie Liagre-Cailles, Mustapha Smail, Yann Nguyen, Evelyne Ferrary, Olivier Sterkers, Ghizlène Lahlou and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Acta neurochirurgica, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Surgery in NF2-Schwannomatosis.Familial cancer · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Hannah DaoudiENT Department, Pitié-Salpêtrière, APHP, Sorbonne University, Paris, France. hannah.daoudi@aphp.fr.
Renato TorresENT Department, Pitié-Salpêtrière, APHP, Sorbonne University, Paris, France.
Isabelle MosnierENT Department, Pitié-Salpêtrière, APHP, Sorbonne University, Paris, France.
Emmanuelle Ambert-DahanENT Department, Pitié-Salpêtrière, APHP, Sorbonne University, Paris, France.
Amélie Liagre-CaillesENT Department, Pitié-Salpêtrière, APHP, Sorbonne University, Paris, France.
Mustapha SmailENT Department, Pitié-Salpêtrière, APHP, Sorbonne University, Paris, France.
Yann NguyenENT Department, Pitié-Salpêtrière, APHP, Sorbonne University, Paris, France.
Evelyne FerraryENT Department, Pitié-Salpêtrière, APHP, Sorbonne University, Paris, France.
Olivier SterkersENT Department, Pitié-Salpêtrière, APHP, Sorbonne University, Paris, France.
Ghizlène LahlouENT Department, Pitié-Salpêtrière, APHP, Sorbonne University, Paris, France.
Michel KalamaridesNeurosurgery Department, Pitié-Salpêtrière, APHP, Sorbonne University, Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThis retrospective monocentric study aimed to evaluate long-term auditory brainstem implant (ABI) function in patients with neurofibromatosis type 2, and to investigate the prognostic factors for ABI use.

methodsBetween 1997 and 2022, 27 patients with at least five years of follow-up underwent implantation with 32 ABIs. At 1- and 5-years post-implantation and at last follow-up, ABIs were classified as used or non-used and the size of the ipsilateral tumor was recorded. For patients who used their ABIs, we assessed speech perception (disyllabic words, MBAA sentences) in quiet conditions with the ABI only, by lip-reading (LR), and with a combination of the two (ABI + LR). Hearing improvement was calculated as

resultsOne year post-implantation, 74% patients were ABI-users and 66% of the ABIs were used. Two of these patients were non-users at five years, and another two at last follow-up (14 ± 5.2 years); 54% of the patients were ABI-users at last follow-up.

conclusionsABIs are indicated in case of bilateral deafness with a non-functional cochlear nerve. Half the patients with ABIs used their implants and auditory performance remained stable over time, except in cases of ipsilateral tumor growth.

Indexed as

NeurofibromatosesNeurofibromatosis 2Speech PerceptionAdultAuditory Brain Stem ImplantationAuditory Brain Stem ImplantsFemaleFollow-Up StudiesHumansMaleMiddle AgedNeurilemmomaRetrospective StudiesSkin NeoplasmsTreatment OutcomeYoung AdultAuditory brainstem implantHearing evaluationHearing lossTumor progressionVestibular schwannoma

Identifiers

PMID39356313

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.